News Sentiment

IMNN sentiment intelligence

Imunon Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.02 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+5.8% over one week, +0.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

OTC Markets Life Sciences Investor Forum: Stacy Lindborg, PhD, President, CEO, and Board Director, of Imunon with Zacks SCR’s David Bautz, PhD

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 5.8% Price confirming higher
Trend fit Trend inactive 0.0% over four weeks
Fair value -80.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 46
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
TradingView 12
GlobeNewswire 6
Market source 5
Investing.com Nigeria 3
GuruFocus 2
simplywall.st 2
Zacks Small Cap Research 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 16
Balance sheet 7
Analyst action 2
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 56
GuruFocus Direct company coverage

Insider Sell: Susan Eylward Sells Shares of Imunon Inc (IMNN)

Susan Eylward, General Counsel and Corporate Secretary at Imunon Inc's subsidiary, sold 920 shares of IMNN on July 6, 2026. This transaction brings her total ownership down to 2,896 shares. Over the past year, there have been no insider buys and two insider sells at Imunon Inc, w

Tone
Negative 30/100
Event
Market update
Published
07 Jul 2026 22:39
Source
GuruFocus
Investing.com Nigeria Direct company coverage

Form 4 Imunon Inc For: 7 July By Investing.com

This article from Investing.com announces a Form 4 filing for Imunon Inc. on July 7, 2026. Form 4s typically report changes in beneficial ownership of company stock by insiders. The article notes Imunon Inc. (IMNN) is up 7.69%.

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 21:40
Source
Investing.com Nigeria
Investing.com Direct company coverage

Imunon general counsel Susan Eylward sells $1,729 in company stock

Imunon's General Counsel, Susan Eylward, recently sold 920 shares of company stock for $1,729. This transaction followed her acquisition of the same number of shares, granted in lieu of salary, valued at $1,757. The stock is currently trading near its 52-week low, and company ana

Tone
Negative 38/100
Event
Deals and strategy
Published
07 Jul 2026 21:39
Source
Investing.com
Stock Titan Direct company coverage

Imunon (IMNN) Executive Chairman receives 4,410-share stock grant as salary

Imunon, Inc. Executive Chairman Michael H. Tardugno received a grant of 4,410 shares of common stock at $1.91 per share, issued in lieu of cash for his base salary. This transaction increased his direct ownership to 64,396 shares, with an additional 4,622 shares held indirectly t

Tone
Neutral 50/100
Event
Balance sheet
Published
07 Jul 2026 20:40
Source
Stock Titan
Stock Titan Direct company coverage

Imunon (IMNN) CMO granted stock in lieu of part of salary

Imunon's Chief Medical Officer, Douglas Vincent Faller, received a grant of 1,308 shares of Common Stock on July 2, 2026, at $1.91 per share. This stock grant was provided in lieu of a portion of his base salary, making it a non-market compensation transaction. Following this tra

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:40
Source
Stock Titan
Stock Titan Direct company coverage

Imunon (IMNN) General Counsel reports stock grant and 920-share sale

Imunon, Inc.'s General Counsel, Susan Eylward, reported receiving a stock grant of 920 shares at $1.91 each on July 2, 2026, as part of her base salary. She subsequently sold 920 shares in an open-market transaction at $1.88 each on July 6, 2026. After these transactions, Eylward

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Imunon (IMNN) CEO Stacy Lindborg receives stock grant instead of cash salary

Imunon, Inc.'s President and CEO, Stacy Lindborg, received a grant of 2,534 shares of common stock at $1.91 per share as part of her compensation, in lieu of a portion of her base salary. Following this transaction, Lindborg directly holds 76,722 shares and indirectly holds 778 s

Tone
Neutral 50/100
Event
Balance sheet
Published
07 Jul 2026 20:39
Source
Stock Titan
Moomoo Direct company coverage

Imunon 1Q Loss/Shr 84c >IMNN

Imunon (IMNN) reported a first-quarter loss per share of 84 cents. This financial update provides key information regarding the company's recent performance.

Tone
Negative 24/100
Event
Market update
Published
07 Jul 2026 01:13
Source
Moomoo
The Globe and Mail Direct company coverage

Imunon Names Josh Blacher Interim Chief Financial Officer

Imunon has appointed Josh Blacher as interim Chief Financial Officer, effective July 1, 2026, following the retirement of Jeffrey Church. Blacher, a finance executive from Danforth Health, Inc., will serve as the principal financial and accounting officer. The company's stock, IM

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 05:09
Source
The Globe and Mail
Finviz Direct company coverage

IMNN - Imunon Inc Latest SEC Filings

This article provides the latest SEC filings information for Imunon Inc. (IMNN), alongside a comprehensive financial overview. It details key financial metrics, stock performance data, and insider/institutional ownership figures for the company.

Tone
Negative 41/100
Event
Market update
Published
03 Jul 2026 15:09
Source
Finviz
Stock Titan Direct company coverage

Imunon (NASDAQ: IMNN) appoints Josh Blacher as interim CFO

Imunon, Inc. (NASDAQ: IMNN) has appointed Josh Blacher as its new interim Chief Financial Officer, effective July 1, 2026. This appointment follows the retirement of the previous interim CFO, Jeffrey Church, who will remain with the company as a consultant. Blacher will serve thr

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 20:39
Source
Stock Titan
TradingView Direct company coverage

Imunon CFO Jeffrey Church to Retire; Josh Blacher Named Interim CFO

Imunon has announced that its interim Chief Financial Officer, Jeffrey Church, will retire effective July 1, 2026. Josh Blacher has been named the interim CFO, taking over on the same date. Church will continue as a consultant for Imunon under an amended Consulting Agreement.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 20:39
Source
TradingView
Investing.com Nigeria Direct company coverage

Form 4 Imunon Inc For: 29 June By Investing.com

This article from Investing.com announces the Form 4 filing for Imunon Inc. on June 29th. It is a brief, factual notification regarding a regulatory filing for the company.

Tone
Neutral 50/100
Event
Regulatory and legal
Published
30 Jun 2026 14:12
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Imunon (IMNN) CEO awarded 67,150 shares instead of cash bonus

Imunon, Inc. President and CEO Stacy Lindborg received a stock-based compensation grant of 67,150 shares at $1.72 per share, in lieu of 50% of her 2025 annual cash bonus. Following this transaction, Lindborg directly holds 74,188 shares and indirectly holds 778 shares through a 4

Tone
Neutral 50/100
Event
Balance sheet
Published
30 Jun 2026 01:14
Source
Stock Titan
Stock Titan Direct company coverage

Imunon (IMNN) counsel gets stock bonus, then sells 11,800 shares

Imunon's General Counsel, Susan Eylward, received 14,696 shares of common stock at $1.72 per share as part of her 2025 annual bonus. Shortly after, she sold 11,800 shares in an open-market transaction at a weighted average price of $1.752 per share, retaining 2,896 shares. This t

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 01:14
Source
Stock Titan
GuruFocus Direct company coverage

Insider Sell: Susan Eylward Sells 11,800 Shares of Imunon Inc (I

Susan Eylward, General Counsel and Corporate Secretary at a subsidiary of Imunon Inc, sold 11,800 shares of Imunon Inc (IMNN) on June 29, 2026. After this transaction, Eylward now holds 2,896 shares. Imunon Inc, a biotechnology company, has seen no insider buys but one insider se

Tone
Negative 37/100
Event
Market update
Published
29 Jun 2026 23:14
Source
GuruFocus
Stock Titan Direct company coverage

Imunon (IMNN) chair takes half of 2025 cash bonus in stock grant

Imunon's Executive Chairman, Michael H. Tardugno, received 42,519 shares of common stock valued at $1.72 per share, in lieu of 50% of his 2025 annual cash bonus. This stock grant increases his direct holdings to 59,986 shares, plus an additional 4,622 shares held indirectly throu

Tone
Neutral 50/100
Event
Balance sheet
Published
29 Jun 2026 20:14
Source
Stock Titan
Stock Titan Direct company coverage

Imunon (IMNN) Chief Medical Officer granted 21,896 shares in lieu of 2025 cash bonus

Imunon, Inc.'s Chief Medical Officer, Douglas Vincent Faller, was granted 21,896 shares of common stock at $1.72 per share. This stock grant serves as 50% of his 2025 annual cash bonus, rather than a cash payment. Following this transaction, Faller directly owns 21,896 shares of

Tone
Neutral 50/100
Event
Balance sheet
Published
29 Jun 2026 20:14
Source
Stock Titan
TradingView Direct company coverage

Enterprise value to EBITDA forward of Imunon, Inc. – NASDAQ:IMNN

The article presents financial data for Imunon, Inc. (NASDAQ: IMNN), specifically focusing on its enterprise value to EBITDA forward metric. The content itself seems to be a display from a financial data platform, providing a snapshot of the company's financial overview. It does

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 05:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Imunon, Inc. – DUS:CBO0

The article provides a financial data point for Imunon, Inc. (DUS:CBO0) on its price to earnings forward, indicating "No trades" at market close. The content is primarily a data page from TradingView, displaying financial overview information for the company.

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 20:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Imunon, Inc. – NASDAQ:IMNN

This article provides a brief snapshot of the "Price to sales forward" for Imunon, Inc. (NASDAQ: IMNN). It indicates that the market was closed with no trades at the time of publication. The content primarily shows the financial metric "Period Value Change Change %" for the compa

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 13:40
Source
TradingView
TradingView Direct company coverage

Price to book forward of Imunon, Inc. – NASDAQ:IMNN

This article provides a financial data point for Imunon, Inc. (NASDAQ: IMNN), specifically its "Price to book forward" metric. The content indicates that for this particular period, the value is not available, showing "No trades." It appears to be a stub or an entry from a financ

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 09:39
Source
TradingView
TradingView Direct company coverage

Imunon, Inc. Actuals & Estimates (FWB:CBO0)

This article provides key financial data and analyst insights for Imunon, Inc. (FWB:CBO0), including its stock ticker, price forecasts ranging from 8.61 EUR to 21.53 EUR, and historical price movements. It details recent earnings, revenue, and net income figures, noting that the

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 16:10
Source
TradingView
TradingView Direct company coverage

Imunon, Inc. Actuals & Estimates (DUS:CBO0)

This article provides an overview of Imunon, Inc. (DUS: CBO0) stock, including financial actuals and estimates, analyst forecasts with price targets, and historical price data. It details recent earnings and revenue figures, upcoming earnings release dates, and confirms the compa

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 05:39
Source
TradingView
Seeking Alpha Direct company coverage

Imunon, Inc. (IMNN) Presents at Life Sciences Virtual Investor Forum - Slideshow (NASDAQ:IMNN) 2026-06-26

Imunon, Inc. (IMNN) presented a slideshow at the Life Sciences Virtual Investor Forum. The article highlights that SA Transcripts published the slide deck and is responsible for developing all transcript-related projects for Seeking Alpha. This event provides investors with insig

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 04:10
Source
Seeking Alpha
TradingView Direct company coverage

A41CNR Forecast — Price Target — Prediction for 2027

This article provides a detailed forecast for Imunon, Inc. (A41CNR) stock, including price targets, analyst ratings, and historical performance data. It highlights that analysts have a max estimate of 21.53 EUR and a min estimate of 8.61 EUR for the stock, despite recent declines

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 23:38
Source
TradingView